Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.A survey conducted by the European Medicines Agency has revealed that majority of the patient and consumer groups were satisfied with their interactions with the Agency, according to PharmaTimes.
Subscribe to our email newsletter
Approximately 21 patient and consumer organizations (PCOs) participated in European Medicines Agency (EMEA) activities in 2007 and more than 92% of their representatives expressed satisfaction at the EMEA and PCO interactions. The PCOs were generally involved in reviewing public summaries of scientific assessment reports and package leaflets and providing their insight as users of medicines to EMEA scientific bodies.
However, the groups expressed their desire to extend the interaction further into the product evaluation and guideline preparation activities of the Agency. EMEA said: “As end-users of the medicines that the EMEA evaluates, PCOs have specific knowledge and expertise to offer. This makes them key stakeholders in the work of the EMEA, and the agency is therefore committed to maintaining a strong working relationship with them.”
According to PharmaTimes, the EMEA management board welcomed the survey results and agreed to propose actions for extending the scope of interactions with the PCOs.